key: cord-0871850-opu3ehen authors: Kanteh, Abdoulie; Manneh, Jarra; Jabang, Sona; Kujabi, Mariama A.; Sanyang, Bakary; Oboh, Mary A.; Bojang, Abdoulie; Jallow, Haruna S.; Nwakanma, Davis; Secka, Ousman; Roca, Anna; Amambua-Ngwa, Alfred; Antonio, Martin; Baldeh, Ignatius; Forrest, Karen; Samateh, Ahmadou Lamin; D’Alessandro, Umberto; Sesay, Abdul Karim title: Origin of imported SARS-CoV-2 strains in The Gambia identified from whole genome sequences date: 2020-10-26 journal: bioRxiv DOI: 10.1101/2020.10.26.354969 sha: 7479469c5c51f854a1a67c5d221d395b0de96c77 doc_id: 871850 cord_uid: opu3ehen Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a positive-sense single stranded RNA virus with high human transmissibility. This study generated Whole Genome data to determine the origin and pattern of transmission of SARS-CoV-2 from the first six cases tested in The Gambia. Total RNA from SARS-CoV-2 was extracted from inactivated nasopharyngeal-oropharyngeal swabs of six cases and converted to cDNA following the ARTIC COVID-19 sequencing protocol. Libraries were constructed with the NEBNext ultra II DNA library prep kit for Illumina and Oxford Nanopore Ligation sequencing kit and sequenced on Illumina MiSeq and Nanopore GridION, respectively. Sequencing reads were mapped to the Wuhan reference genome and compared to eleven other SARS-CoV-2 strains of Asian, European and American origins. A phylogenetic tree was constructed with the consensus genomes for local and non-African strains. Three of the Gambian strains had a European origin (UK and Spain), two strains were of Asian origin (Japan). In The Gambia, Nanopore and Illumina sequencers were successfully used to identify the sources of SARS-CoV-2 infection in COVID-19 cases. 136 110-3001) before loading (Fig 1) . 138 Nanopore sequencing library preparation was performed according to the 159 For Nanopore data, sequencing reads were quality checked using MinIONQC, 16 and 160 only reads with a minimum Q score of 7 were included in our subsequent analysis. Table 2 . 198 a range of one to four million reads with average mapping quality of 58 across the 206 reference genome for each sample. To compare the results from both technologies, 207 consensus genomes were generated for each sample and a maximum likelihood 208 phylogenetic tree was constructed Figure 2. A maximum likelihood phylogenetic tree of ten SARS-CoV-2 genomes 212 isolated from The Gambia (Nanopore data) and 11 SARS-CoV-2 strains isolated 213 in different parts of the world. The tree showed the genetic relation of strains maximum likelihood phylogenetic tree of eight SARS-CoV-2 218 genomes isolated from The Gambia (Illumina data) and 11 SARS-CoV-2 strains 219 isolated in different parts of the world. The tree showed the genetic relation of 220 strains Six genomes (4 samples from Case A, 1 from case D and 1 from case C) from the Gambian samples clustered with the European (Spanish and United Kingdom) SARS This is not surprising given that these patients had been in Europe 224 before arriving in The Gambia. Although viruses are known to mutate and change 225 rapidly, 19,20 the viral genome of case A clustered on the same node at different time While Illumina sequencing may be more accurate in determining within-257 sample-diversity, Nanopore data can help with the understanding of the linkage 258 between SNPs within individual virions. The Nanopore platform with its flexibility for 259 number of samples per run, and the generation of data in real-time and at a reasonable 260 cost makes it most suitable for outbreaks. Therefore, with our optimised and ready-to-261 go workflow, we are set to generate data for tracking SARS-CoV-2 in The Gambia and 262 other African countries within 24 hours of sample reception. This would go a long way 263 in providing knowledge on the molecular epidemiology of this disease We have demonstrated that the Nanopore platform with the flexibility of high-end 269 desktop sequencer (GridION) to the portable sequencer (MinION) in combination with 270 the ARTIC protocol and workflow allows for cost-effective (wide range for the number 271 of runs and samples per flow cell), and near real-time generation of pathogen 272 sequence data. Our analysis has shown that the SARS-CoV-2 strains identified in The 321 World Finance Health Policy COVID-19 and Italy : what next ? Lancet 325 Comment COVID-19 pandemic in west Africa Articles Genomic 334 characterisation and epidemiology of 2019 novel coronavirus : implications for 335 virus origins and receptor binding Zoonotic origins of human 338 coronaviruses The 340 Extent of Transmission of Novel Coronavirus in International Journal of Infectious Diseases 346 First known person-to-person transmission of severe acute respiratory 347 syndrome coronavirus 2 ( SARS-CoV-2 ) in the USA Genomic characterization of the 2019 novel human-349 pathogenic coronavirus isolated from a patient with atypical pneumonia after 350 visiting Wuhan Comparative genomics suggests limited 352 variability and similar evolutionary patterns between major clades of SARS-353 Sequence 355 analysis MinIONQC : fast and simple quality control for MinION sequencing 356 data Babraham Bioinformatics -FastQC A Quality Control tool for High Throughput 360 Sequence Data Why are RNA virus mutation rates so damn high?